Nukleus Office Solutions Limited approved its Employee Stock Option Scheme-I 2026 during a board meeting on August 29, 2026. The scheme grants 201,600 options to eligible employees to attract and retain talent.

The Board of Directors considered the recommendation of the Nomination and Remuneration Committee before approving the plan. The move aligns employee interests with the company's long-term growth. Implementation is subject to shareholder approval via a Special Resolution and other regulatory consents.

Key Terms of the ESOP Scheme

The board approved specific terms for the grant, vesting, and exercise of the options under the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

Options vest upon completion of one year from the date of grant, subject to continued employment and performance-linked conditions. Vested options must be exercised within two years from the date of grant. The exercise price will be determined according to prevailing laws and scheme terms at the time of grant.

Next Steps

The board authorized the convening of a General Meeting to seek shareholder consent for the scheme. The draft notice and explanatory statement were also approved. Mr. Vinay Rathore, Company Secretary and Compliance Officer, was authorized to handle necessary filings with regulatory authorities.

Nukleus Office Solutions will host a virtual meeting with analysts and institutional investors on August 13, 2026, at 4:00 PM IST. The company disclosed the schedule on August 8, 2026, via a filing to BSE Limited under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This engagement provides market participants an opportunity to interact with management regarding the company’s operations and strategy based on publicly available data.

The meeting is structured as a group virtual session, allowing multiple analysts or institutions to participate simultaneously. Management emphasized that discussions will be strictly confined to generally available information. No Unpublished Price Sensitive Information (UPSI) will be shared during the interaction, ensuring compliance with regulatory norms regarding fair disclosure.

Meeting Details

Investors and analysts interested in attending must register by emailing info@akmiladvisors.com . Akmil Strategic Advisors Private Ltd. is facilitating the registration process for this event. The company noted that the schedule is subject to change due to exigencies on the part of the analysts, investors, or the company itself.

Regulatory Compliance

The intimation was signed by Vinay Rathore, the Company Secretary and Compliance Officer of Nukleus Office Solutions Limited. His membership number is 75848. The filing underscores the company’s adherence to SEBI’s transparency requirements for listed entities. By proactively scheduling this interaction, the company aims to maintain open communication channels with its investor base while strictly managing information flow to prevent any regulatory breaches related to UPSI.

What the Numbers Show

While this announcement does not contain financial metrics, the decision to hold a dedicated analyst meet often signals a period of strategic clarity or upcoming material developments that the company wishes to contextualize for the market. The reliance on a third-party advisor, Akmil Strategic Advisors Private Ltd., for registration suggests a structured approach to managing investor relations, ensuring that only qualified participants gain access to the management team. This controlled environment helps in maintaining the integrity of the dialogue and ensures that questions are relevant and professional.